Schedule 13G ownership disclosure

Amneal Pharmaceuticals Inc

Security class unavailable · CUSIP: 03168L105

Event date: 2024-03-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,558,303
Percent of class
2.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-050772
Form type
SC 13G/A
Filer
Amneal Pharmaceuticals, Inc.
CIK
CIK 1723128
Filed
Apr 24, 2024
Reporting period
Mar 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub